For vaginal health and balance.
Marketing tools Women's health
Download the brochureProduct background
Respecta® Balance Gel is a medical device adjuvant in the treatment of vaginitis and vaginosis specifically studied for rebalancing the physiological pH and vaginal microbiota.
The vaginal environment is populated by numerous bacterial species (such as lactobacilli, gardnerella, streptococci, etc.) that in physiological conditions are in balance (eubiosis) with a clear prevalence of lactobacilli. However, this fine balance can be altered by several factors including antibiotic consumption, use of overly aggressive cleansers, irritative or allergic conditions. Consequently, potentially pathogenic microorganisms such as Candida and Gardnerella take over the Lactobacillus population, creating a state of dysbiosis up to causing pathological conditions such as bacterial vaginosis, aerobic vaginitis, or vulva-vaginitis caused by Candida spp. (VVC). In particular, in the case of dysbiosis, vaginal pH often increases creating a vicious circle with a progressive reduction of the defenses of the vaginal mucosa.
Respecta® Balance Gel is suitable for restoring the physiological vaginal pH, favoring the proliferation and growth of beneficial microorganisms (lactobacilli) that normally colonize healthy tissue.
Key ingredients
Glycogen, prebiotic fiber, hyaluronic acid, and lactic acid.
Target
- Vaginal dysbiosis
- Bacterial and yeast infections
Benefits and features
- Restores physiological vaginal pH
- Promotes the growth of beneficial microorganism
- Provides hydration and protection to the vaginal tissue
- Promotes the formation of protective biofilm
- Works well in combination with standard oral drug/probiotic treatment
Scientific evidence and proprietary studies
In vitro mechanistic study.
Effects of Farnesol on Drug-Resistant and Non-Resistant Candida albicans: Implications for Cosmetic and Pharmaceutical Applications (Yar et al 2020).
In Vitro Exploration of Probiotic Bacteria Interactions with Candida Using Culture Techniques to Model Dysbiotic Conditions in Colonized Tissues (Wittman et al 2021).
*Registered as “Respecta® Gel Vaginale (NB 0476)”.
RELATED PRODUCTS
Marketing tools Women's health
Download the brochure| Product name | Respecta® Balance Gel* |
| Status | Medical device class IIa |
| Key ingredients | Glycogen, prebiotic fiber, hyaluronic acid and lactic acid |
| Target and indication | Adjuvant in the treatment of vaginitis and vaginosis |
| Claims EFSA | n. a. |
| Scientific evidence and study | Mechanistic study |
| Pharmaceutical form | Gel (single-use tubes or tube with vaginal applicator) |